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Carpal tunnel syndrome is the most common com-
pressive neuropathy of the upper extremity. Over 500,000 
carpal tunnel releases are performed each year within the 
United States, with direct costs exceeding 2 billion dollars 
annually.1,2 There has been an increasing emphasis within 
healthcare to deliver more cost-effective and efficient 
surgical services while still maintaining the highest quality 
of patient care.
Substantial literature within the field of hand surgery has 
suggested that one effective method of surgical cost reduc-
tion is the utilization of a procedure room setting (PR), 
rather than the operating room setting (OR) for minor pro-
cedures.3–13 Compared with the more traditional OR surgical 
setting with full sterility utilizing regional or general anes-
thesia, office-based PR surgical settings for minor hand pro-
cedures use field sterility under pure local anesthesia with 
lidocaine and epinephrine. Generally, a tourniquet is not 
used in the PR setting. Open carpal tunnel releases (oCTR), 
trigger finger release, de Quervain release, and other minor 
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Background: Performing open carpal tunnel release (oCTR) in an office-based pro-
cedure room setting (PR) decreases surgical costs when compared with the operating 
room (OR). However, it is unclear if the risk of major medical, wound, and iatrogenic 
complications differ between settings. Our purpose was to compare the risk of major 
medical complications associated with oCTR between PR and OR settings.
Methods: Utilizing the MarketScan Database, we identified adults undergoing iso-
lated oCTR between 2006 and 2015 performed in PR and OR settings. ICD-9-CM 
and/or CPT codes were used to identify major medical complications, surgical site 
complications, and iatrogenic complications within 90 days of oCTR. Multivariable 
logistic regression was used to compare complication risk between groups.
Results: Of the 2134 PR and 76,216 OR cases, the risk of major medical complica-
tions was 0.89% (19/2134) and 1.20% (914/76,216), respectively, with no differ-
ence observed in the multivariable analysis (adjusted odds ratio [OR] 0.84; 95% 
CI 0.53–1.33; P = 0.45). Risk of surgical site complications was 0.56% (12/2134) 
and 0.81% (616/76,216) for the PR and OR, respectively, with no difference in the 
multivariable analysis (OR 0.68; 95% C.I. 0.38–1.22; P = 0.19). Iatrogenic complica-
tions were rarely observed (PR 1/2134 [0.05%], OR 71/76,216 [0.09%]), which 
precluded multivariable modeling.
Conclusion: These results support a similar safety profile for both the PR and OR 
surgical settings following oCTR with similar pooled major medical complica-
tions, pooled wound/surgical site complications, and iatrogenic complications. 
(Plast Reconstr Surg Glob Open 2021;9:e3685; doi: 10.1097/GOX.0000000000003685; 
Published online 12 July 2021.)
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procedures are feasible using WALANT techniques (wide-
awake, local-only anesthesia, no tourniquet) in the PR set-
ting, which has been proposed to improve the value of care 
for patients.3–6,8,9,11,12,14–16 Specific to oCTR, direct costs may 
range from four-fold9 to 30-fold3 greater for the OR, when 
compared with the PR. In addition to utilizing the WALANT 
technique, decreased medical consultation and testing with 
utilization of the PR setting may further lead to lower preop-
erative and overall costs.13,14
Value of care is equivalent to the treatment outcome, 
or level of improvement, per unit cost.17–20 Improving 
clinical or functional outcomes while maintaining a com-
parable treatment cost increases the value of care within 
orthopedic surgery. Additionally, lowering surgical costs 
while maintaining clinical and functional outcomes also 
improves the value of care. Utilizing a value-based pay-
ment model has expanded efforts to enhance the treat-
ment outcomes and effectiveness of healthcare delivery 
within the United States and to reduce avoidable costs.21
In addition to cost, other vital components in evaluat-
ing value of care include clinical and functional outcomes, 
as well as safety and complication rates. However, there 
remains a paucity of evidence as to the safety profile of uti-
lizing the PR setting for oCTRs and how it compares to the 
complication rate of utilizing the OR, which is the tradi-
tional setting for CTR surgery using regional, sedation, or 
general anesthesia. A subjectively low postoperative com-
plication rate has been reported for various hand surgeries 
performed in the PR setting, although most do not specifi-
cally investigate complication profiles or specifically com-
pare complication rates between PR and OR settings.3,4,6,11,22 
Among studies evaluating PR complications, Leblanc et al 
published a multicenter noncomparative study evaluating 
postoperative infection rates following oCTR performed in 
the PR setting.10 Although the results were promising, with 
rates of 0.4% and 0% for superficial and deep infections, 
other medical complications and iatrogenic complications 
to neurovascular or tendon structures were not evaluated. 
Other studies have attempted to address the PR surgical 
setting safety by comparing complication rates between 
PR and OR, reporting zero complications for both settings 
among oCTR patients and low complication rates for trig-
ger finger release patients.8,23 However, both of these stud-
ies were limited by small sample sizes and under-powering 
for the purpose of drawing strong conclusions.24
The primary purpose of our study was to evaluate 
our hypothesis that the risk of major medical complica-
tions associated with oCTR was similar between PR and 
OR settings in a large, geographically-diverse population-
based cohort. Our secondary purpose was to evaluate the 
hypothesis that following oCTR, the risk of surgical site 
and iatrogenic complications (neurovascular or tendon 
injury) are similar between PR and OR surgical settings.
METHODS
Definition of PR and OR Populations
In this prospective cohort study, individuals aged 18–
64 years who underwent oCTR surgery from 7/1/2006 
to 6/30/2015 were identified using the IBM MarketScan 
Commercial Database. Due to the deidentification and 
limited dataset of the MarketScan database, this study was 
considered exempt by the University of Utah Institutional 
Review Board and the Washington University in St. Louis 
Human Resource Protection Office. Included in this 
database is information regarding enrollment, medical 
and outpatient pharmacy claims, data for dependents, 
employees, and individuals with Consolidated Omnibus 
Budget Reconciliation Act (COBRA) continuation cov-
ered by employer-sponsored and other commercial health 
insurance plans. The MarketScan database is a prospec-
tive database that encompasses over 150 million patients 
throughout the study’s duration, with information contrib-
uted by commercial health insurance plans and employ-
ers. Not included in the database are individuals 65 years 
and older, uninsured individuals, workers’ compensation, 
government-sponsored plans, and individuals with other 
types of private insurance.
Using the current procedural terminology, fourth edi-
tion (CPT-4) code 64721 for oCTR coded by a provider, 
we identified individuals undergoing oCTR from the 
inpatient and outpatient medical claims files. A diagno-
sis of carpal tunnel syndrome using the International 
Classification of Disease, ninth revision, clinical modifi-
cation 354.0 (ICD-9-CM 354.0) on the claim line for the 
procedure was required. To assess complications and 
comorbidities, 180 days of medical insurance coverage 
enrollment before surgery and 90 days following surgery 
was required. The OR surgical setting was identified by 
utilizing uniform billing codes to identify if the procedure 
took place in the OR based on the revenue center code 
for major OR services (0360, 0361). The PR surgical set-
ting was identified on the surgeon claim line via a place-
of-service code of 11 (in-office procedure). Additionally, 
there was no associated OR revenue center code for OR/
ambulatory surgery services (0360, 0361, or 0490). There 
was also no associated claim for general, regional, seda-
tion, or nerve block anesthesia on the day of the surgery.
Persons with unrelated procedures on the date of 
oCTR were excluded to compare outcomes in patients 
with isolated oCTR depending on the surgical setting. 
Unrelated procedures comprised a broad range of CPT-4 
codes with the exception of iatrogenic-related procedures 
and nerve block codes. To avoid excluding patients with 
intraoperative complications that were treated during 
the index oCTR surgery, we included procedures on the 
oCTR date that were potentially related to address pos-
sible iatrogenic injuries.
The exclusions for our study are summarized 
in Supplemental Digital Content 1. (See appendix, 
Supplemental Digital Content 1, which displays Appendix 
I: Summary of study exclusions. Appendix II: Coding used 
to identify and exclude noniatrogenic injuries. Appendix 
III: Coding used to identify major medical complications. 
Appendix IV: Coding used to identify surgical wound 
complications. Appendix V: Coding used to identify iat-
rogenic surgical complications. Appendix VI: Summary 
and comparison of comorbidities for PR and OR groups. 
http://links.lww.com/PRSGO/B707.)
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We included only the initial procedure that met quali-
fication requirements for patients who had multiple oCTR 
procedures during the study interval. We excluded indi-
viduals with noniatrogenic injuries (eg, rupture, injury to 
the nerves/vessels/tendons associated with oCTR, open 
wound) (SDC1: Appendix II, http://links.lww.com/
PRSGO/B707) that occurred within 30 days before sur-
gery. In addition, oCTR procedures in persons coded for 
a related surgery in the 180 days before the oCTR date, 
suggesting that the oCTR was secondary to the prior 
procedure, were excluded. To focus on nonemergent, 
uncomplicated oCTR procedures, we excluded any pro-
cedures associated with an emergency department visit or 
during an inpatient admission.
Identification of Underlying Comorbidities and Other 
Potential Risk Factors for Complications
We utilized the Elixhauser classification to identify 
comorbidities.25,26 Facility coding in one or more inpa-
tient hospitalization and/or 2 or more outpatient claims 
spaced at least 30 days apart were required, exclud-
ing outpatient claims regarding alcohol abuse, tobacco 
abuse, drug abuse, weight loss, or obesity.27 Active smok-
ing status was identified using diagnostic coding (ICD-9 
305.1, 649.0x).
Identification of Major Medical and Surgical Outcomes
The primary outcome of our study was any major 
medical complications within 90 days following oCTR. All 
medical complications of interest were acute events only. 
Thus, a single code was necessary within 90 days of the 
surgery. We determined major medical complications of 
interest as ICD-9-CM diagnosis/procedure codes for any 
of the following: respiratory failure, cardiac/respiratory 
arrest, congestive heart failure exacerbation, acute myo-
cardial infarction, acute deep vein thrombosis, acute pul-
monary embolism (PE), acute renal failure, postoperative 
shock, acute stroke, transient ischemic attack, and death 
(specific coding provided in SDC1: Appendix III. http://
links.lww.com/PRSGO/B707).
We utilized ICD-9-CM diagnosis or CPT-4 codes for surgical 
site complications. Such complications included any nonheal-
ing wound, wound disruption, surgical site infection, hemor-
rhage complicating a procedure, hematoma, and seroma 
(specific coding provided in SDC1: Appendix IV. http://
links.lww.com/PRSGO/B707). We defined iatrogenic com-
plications as any new neurovascular or tendon structure injury 
that was not previously coded within the 6 months pre-oCTR 
but was diagnosed and/or surgically-treated within 90 days 
post-oCTR (specific coding provided in SDC1: Appendix V. 
http://links.lww.com/PRSGO/B707).
Statistical Methods
To determine factors associated with medical, surgical, 
and iatrogenic complications, we utilized a multivariable 
logistic regression. We used the location of the surgery 
as the primary exposure forced in the model. Variance 
inflation factors were utilized to assess the potential mul-
ticollinearity of independent variables. In the initial full 
models, we included variables with a P value less than 0.2 
in bivariate analysis or with clinical/biologic plausibility. 
We defined a P value less than 0.1 as the threshold for 
retention of all variables as they were removed in a step-
wise backward manner. We compared the demographics 
and complication rates between PR and OR groups using 
Fisher’s exact test or chi-squared tests for binary variables 
and Student’s t or Mann-Whitney U tests for continuous 
variables.
A power calculation was performed utilizing the 
observed ratio of OR to PR cases (35.7:1). To achieve 80% 
power at a 95% confidence level, a total of 1488 PR patients 
and 53,122 OR patients would be needed to discriminate 
a difference of 0.75% for major medical complications 
(0.75% versus 1.5%) on the two-tailed two-proportion test. 
All statistical analyses were performed in SAS version 9.4 
(Cary, N.C.), with P < 0.05 considered statistically significant.
Fig. 1. illustration of relative risks/odds ratios for pooled major medical complications and surgical site 
complications between procedure room and operating room settings. Note that there is no statisti-
cal difference between adjusted pooled major medical and adjusted pooled surgical site complication 
risks between procedure room and operating room settings.
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RESULTS
We identified 2,134 patients treated with isolated oCTR in 
the PR, and 76,216 in the OR. Subjects were excluded under 
the following conditions: lack of health insurance coverage in 
the 180 days before index and/or the 90 days post procedure 
(n = 83,131), presence of coding for a noniatrogenic injury 
in the 30 days before oCTR (n = 2835), a related surgery in 
the 180 days before the oCTR (n = 8526), another CPT code 
in the surgical range on the oCTR date (n = 79,699), evi-
dence of an ER visit on the oCTR date (n = 2914), oCTR per-
formed after the date of admission in the inpatient setting 
(n = 49), inability to determine performance in the OR or PR 
(n = 114,606), and subsequent oCTR procedures 
(n = 16,441). Of included subjects, the mean age was 50 ± 9 
years, with 66.8% being women. Additional demographics 
are provided in Table 1. Smoking status and the frequency 
of comorbidities for PR and OR groups are shown in SDC1. 
(See SDC 1: Appendix VI. http://links.lww.com/PRSGO/
B707.)
Major Medical Outcomes
The crude pooled risk of a major medical complica-
tion was 0.89% (19/2134) for the PR group and 1.20% 
(914/76,216) for the OR group (P = 0.19; Table 2). There 
was no significant difference in major medical complica-
tion risk based on the surgical setting in the multivariable 
analysis (adjusted odds ratio 0.84 for PR versus OR; 95% 
CI 0.53–1.32; P = 0.45). This is illustrated in Figure 1. In 
contrast, hypertension, diabetes, drug abuse, anemia, 
rheumatoid arthritis/collagen vascular disease, chronic 
pulmonary disease, neurologic disorders, psychological 
disorders/psychoses, hypothyroidism, older age, and male 
gender were associated with a significantly increased risk 
of a major medical complication (Table 3).
Surgical Outcomes
The crude pooled risk of surgical site complica-
tions was 0.56% (12/2134) for the PR group and 0.81% 
(616/76,216) for the OR group (P = 0.21). The risk of sur-
gical site complications for both settings are provided in 
Table 4. In the multivariable analysis, no significant asso-
ciation existed between surgical setting and surgical site 
complications (adjusted odds ratio 0.68 for PR versus OR; 
95% C.I. 0.38–1.22; P = 0.19; Table 5). This is illustrated in 
Figure 1. Factors associated with an increased risk of sur-
gical site complications included chronic pulmonary dis-
ease, diabetes, obesity, psychological disorders/psychoses, 
solid tumor, male gender, and smoking, while the north 
central region of the United States (compared with the 
South) was associated with a significantly lower risk of sur-
gical site complications (Table 5).
The crude pooled risk of iatrogenic surgical complica-
tions was 0.05% (1/2134) for the PR group, and 0.09% 
(71/76,216) for the OR group (P > 0.99 Fisher’s exact 
test; Table 6). Multivariable modeling was precluded due 
to the lack of adequate sample size secondary to the rarity 
of iatrogenic surgical complications.
DISCUSSION
Our main finding was that oCTR performed in the PR 
setting was associated with a low risk of pooled major med-
ical complications that was similar to the rate observed 
for patients treated in a traditional OR setting. Within 90 
days of surgery, we observed that 0.89% of PR patients and 
1.20% of OR patients suffered a major medical complica-
tion, which was not significantly different. In light of how 
this study was powered, we conclude that the risk of major 
medical complications for PR and OR settings are no dif-
ferent within a threshold of less than 0.75%. These find-
ings suggest that performing oCTR in the PR setting is 
safe and comparable to choosing the OR as the surgical 
setting from a medical safety standpoint.
Although we could not identify a large compara-
tive study comparing complication rates between PR 
and OR settings, our results in regard to major medical 
Table 1. Demographic Data
Variable PR (n = 2134) OR (n = 76,216) P
Age    
 18–39 258 (12.09%) 10,992 (14.42%) Reference
 40–49 538 (25.21%) 19,819 (26.00%) <0.001
 50–59 911 (42.69%) 32,507 (42.65%) <0.01
 60 and older 427 (20.01%) 12,898 (16.92%) <0.001
Anesthesia type    
 General or regional 0 (0.00%) 63,351 (83.12%) NA
 Sedation 0 (0.00%) 100 (0.13%) —
 Local 2134 (100%) 12,765 (16.75%) —
 Postoperative nerve block 0 (0.00%) 2405 (3.16%) —
Insurance type    
 HMO or POS with capitation 849 (39.78%) 8889 (11.66%) <0.001
 All other plan types 1285 (60.22%) 67,327 (88.34%) —
Region    
 Northeast 239 (11.20%) 12,433 (16.31%) 0.651
 North Central 491 (23.01%) 27,807 (36.48%) 0.069
 South 519 (24.32%) 28,068 (36.83%) Reference
 West 885 (41.47%) 7908 (10.38%) 0.006
Residence type    
 Urban 1536 (71.98%) 55,198 (72.42%) 0.65
 Rural 598 (28.02%) 21,018 (27.58%) —
Gender    
 Men 717 (33.60%) 25,275 (33.16%) 0.672
 Women 1417 (66.40%) 50,941 (66.84%) —
Continuous variables were analyzed using logistic regression, and categorical variables were analyzed using the chi-squared test.
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complications following oCTR are consistent with previ-
ous literature for minor hand surgeries. Lipira et al found 
the risk of myocardial infarction, pulmonary embolism, 
shock, stroke, hemorrhage, or nerve injury for outpa-
tient hand surgery to each be less than 0.1%.24 Although 
an OR comparison group was not studied, Bismil et al 
additionally found no intraoperative complications in 
their analysis of 1000 consecutive cases of various upper 
limb orthopedic surgeries utilizing a safe, efficient, 
and effective one-stop (patient seen and treated in one 
appointment) wide-awake (local anesthesia only) hand 
surgery service they developed as an alternative to the OR 
surgical setting.28
Secondary study findings pertain to the risk of pooled 
surgical site and wound complications, which were infre-
quent and similar between PR and OR settings. Our 
observed risk of wound complications, ranging from 
0.56% in the PR group to 0.81% for the OR, is consis-
tent with the 0.32% infection rate observed by Werner 
et al among over 450,000 CTR surgeries performed.29 A 
breakdown by surgery setting or anesthesia type was not 
provided, and the authors excluded patients undergo-
ing simultaneous distal radius ORIF, but did not exclude 
other concomitant procedures. Our study also found a 
0.56% surgical site infection rate for the PR group and 
0.81% for the OR group, consistent with Lipira et al’s 
reported 1.1% in 10,646 patients who underwent surgical 
procedures of the hand or wrist24 and Tosti et al’s 0.66% 
after 600 consecutive elective soft tissue hand surgeries.30 
Maliha et al found no difference in intraoperative and 
postoperative complication rates, infection rates, wound 
healing complications, or recurrences for patients who 
underwent trigger finger release in an OR versus PR set-
tings.8 However, this study was limited in statistical power, 
with only 39 PR and 37 OR patients, which precludes 
forming statistically-sound, firm conclusions about poten-
tial differences in these rare complications. It is impor-
tant to note that although we found a significantly lower 
rate of wound disruption in the PR group (0.05% versus 
0.31%), this unadjusted finding did not account for the 
higher rate of comorbidities in the OR group, including 
diabetes and obesity, and in terms of the main secondary 
outcome (pooled complication risk), there was no differ-
ence between PR and OR groups.
Lastly, we found low rates of pooled iatrogenic compli-
cations in our cohorts. Specifically, the pooled iatrogenic 
complication rate was 0.09% for the OR group and 0.05% 
for the PR group, with no difference between surgical set-
tings. Due to the rarity of these complications, we cannot 
draw strong conclusions, other than the observation that 
these issues are infrequent in general following oCTR 
in both surgical settings. This finding is congruent with 
prior literature that observed no iatrogenic complica-
tions among 1404 procedure room surgical encounters31 
and absence of such complications in two independent 
smaller studies.8,28 This finding is additionally supported 
by Lipira et al, who detailed a nerve injury rate of less than 





(n = 76,216) P*
Pooled major medical  
 complications 19 (0.89%) 914 (1.20%) 0.194
 Acute MI 2 (0.09%) 47 (0.06%) 0.387
 Acute stroke 12 (0.56%) 436 (0.57%) 0.953
 TIA 4 (0.19%) 122 (0.16%) 0.589
 Death 0 (0.00%) 4 (0.01%) >0.999
 Cardiac/respiratory  
 arrest
1 (0.05%) 10 (0.01%) 0.262
 Respiratory failure 1 (0.05%) 67 (0.09%) >0.999
 Acute PE 0 (0.00%) 96 (0.13%) 0.118
 Acute DVT 2 (0.09%) 128 (0.17%) 0.590
 Congestive heart  
 failure exacerbation
0 (0.00%) 30 (0.04%) >0.999
 Acute renal failure 2 (0.09%) 130 (0.17%) 0.591
 Postoperative shock 0 (0.00%) 1 (0.00%) >0.999
*Comparisons for pooled major medical complications, and acute stroke, were 
determined using chi-squared test. The other comparisons were made using 
Fisher’s exact test.
Table 3. Multivariable Logistic Regression Model for Pooled Major Medical Complication Risk
Variable*† Coefficient
95% Wald Confidence Limits
PUpper Limit Lower Limit
Surgical setting (PR versus OR) 0.84 0.53 1.33 0.450
Elixhauser comorbidity index variables — — — —
 Anemia 3.33 2.46 4.51 <0.0001
 Rheumatoid arthritis/collagen vascular disease 2.21 1.62 3.02 <0.0001
 Chronic pulmonary disease 2.39 1.93 2.98 <0.0001
 Diabetes 2.16 1.85 2.52 <0.0001
 Drug abuse 2.08 1.19 3.64 0.010
 Hypertension 1.80 1.56 2.08 <0.0001
 Neurologic disorders 2.16 1.46 3.19 0.000
 Psychological disorders/psychosis 1.42 1.05 1.93 0.024
 Hypothyroidism 1.46 1.10 1.92 0.008
Sex (men versus women) 1.42 1.24 1.62 <0.0001
Age category (versus 18–39) — — — —
 40–49 1.95 1.36 2.81 <0.0001
 50–59 3.25 2.32 4.56 <0.0001
 60+ 4.81 3.40 6.81 <0.0001
*Note that the following additional variables were included in the model but were eliminated through a backward term selection method: alcohol abuse, obesity, 
solid tumor without metastasis, and smoking. Rural (versus urban) residence, region, and insurance type were also nonsignificant.
†Note that the following Elixhauser comorbidity variables were not analyzed in this model due to insignificance in univariate analysis (P > 0.20) or due to counts < 
5: AIDS, chronic blood loss anemia, congestive heart failure, coagulopathy, depression, liver disease, lymphoma, fluid and electrolyte disorders, metastatic cancer, 
paralysis, peripheral vascular disease, pulmonary circulation disease, renal failure, valvular disease, and weight loss.
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0.1% in both surgical settings for their cohort of 10,646 
patients who had undergone surgical procedures of the 
hand or wrist in the inpatient or outpatient setting.24
Our study contains several limitations that deserve 
mention. Our power calculation utilized the observed 
ratio of OR to PR cases (35.7:1) to achieve 80% power at 
a 95% confidence level, which allowed us to calculate the 
number of patients needed in each surgical setting to dis-
criminate a difference of less than 0.75% for major medi-
cal complications on the two-tailed two-proportion test. 
We felt that we powered our study to a clinically mean-
ingful low threshold, but the determination of the most 
appropriate threshold is somewhat subjective. Our study 
had potential for coding errors given the administrative 
database that was utilized to identify our cohort. The 
MarketScan database is limited in scope and is not com-
prehensive of all data variables. Due to the claims nature 
of the database, it is possible that we are under-capturing 
minor complications that are not tied to reimbursement. 
However, major complications that require re-operation 
and are thus tied to reimbursement are likely to be coded 
more accurately. We did not collect data regarding local 
anesthesia complications because we were unable to 
achieve this level of granularity with this database study, 
although this has been noted to be very rare or not 
reported in large series of WALANT cases.10,32 The gener-
alizability of our study to older or more socially deprived 
patient populations is unclear, given our utilization of 
the MarketScan database, which solely comprises com-
mercially insured patients younger than 65 years of age. 
Our study only looked at complications within a 90-day 
postoperative period. However, the NSQIP database33 
only looks at 30 days postoperatively for complications; 
so we feel our 90-day period is fairly comprehensive, but 
it is possible that later complications or revisions could 
be missed by our analysis. We also excluded a large num-
ber of patients. It is possible that these exclusions could 
have an impact on the results, but we do not know if 
those excluded differ from those included in our study. 
The interpretation of our results is somewhat limited in 
regard to commenting on what extent the surgical setting 
versus the anesthesia type impacted the observed similar 
safety profile and complications among the two patient 
groups, as the PR setting is linked to local-only anesthe-
sia. Lastly, the rarity of iatrogenic surgical complications 
precluded our ability to perform a multivariable analysis 
to control for demographics and comorbidities among 
cohorts.





(n = 76,216) P*
Pooled surgical site  
 complications 12 (0.56%) 616 (0.81%) 0.209
 Surgical site infection 10 (0.47%) 303 (0.40%) 0.608
 Surgical site wound  
 disruption
1 (0.05%) 235 (0.31%) 0.024
 Surgical site seroma 0 (0.00%) 28 (0.04%) >0.999
 Surgical site hematoma 1 (0.05%) 25 (0.03%) 0.512
 Surgical site nonhealing 
 wound
1 (0.05%) 87 (0.11%) 0.735
 Hemorrhage  
 complicating a procedure
0 (0.00%) 24 (0.03%) >0.999
*Comparisons for pooled surgical site complications, and surgical site 
infection, were determined using Chi-squared test. The other comparisons 
were made using Fisher’s Exact Test.
Table 5. Multivariable Logistic Regression Model for Pooled Surgical Site Complication Risk
Variable*† Coefficient
95% Wald Confidence Limits
PUpper Limit Lower Limit
Surgical setting (PR versus OR) 0.69 0.38 1.22 0.200
Elixhauser comorbidity index variables — — — —
 Chronic pulmonary disease 1.67 1.21 2.30 0.002
 Diabetes 1.64 1.33 2.03 <0.0001
 Obesity 1.53 1.23 1.89 0.000
 Psychological disorders/psychosis 1.64 1.15 2.33 0.007
 Solid tumor 2.60 1.57 4.30 0.000
Region (versus South) — — — —
 North central 0.82 0.68 0.98 0.032
 North east 0.85 0.67 1.08 0.173
 West 1.17 0.92 1.51 0.205
Gender (men versus women) 1.32 1.13 1.56 0.001
Smoking 1.36 1.10 1.69 0.004
*Note that the following additional variables were included in the model but were eliminated through a backward term selection method: age, depression, hyper-
tension, hypothyroidism, and neurologic disorders.
†Note that the following Elixhauser comorbidity variables were not analyzed in this model due to insignificance in univariate analysis (P > 0.20) or due to counts < 
5: AIDS, chronic blood loss anemia, congestive heart failure, coagulopathy, depression, liver disease, lymphoma, fluid and electrolyte disorders, metastatic cancer, 
paralysis, peripheral vascular disease, pulmonary circulation disease, renal failure, valvular disease, and weight loss. Rural (versus urban) residence and insurance 
type were also nonsignificant.
Table 6. Unadjusted Rates of Iatrogenic Surgical  
Complication Risk
 PR (n = 2060) OR (n = 73925) P*
Pooled iatrogenic  
 complications
1 (0.05%) 71 (0.09%) >0.999
 New nerve injury 1 (0.05%) 41 (0.05%) >0.999
 New blood vessel 
  injury
0 (0.00%) 8 (0.01%) >0.999
 New tendon injury 0 (0.00%) 22 (0.03%) >0.999
 Iatrogenic injury 1 (0.05%) 30 (0.04%) 0.575
*Comparisons were made using Fisher’s exact test.
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CONCLUSIONS
In conclusion, our findings support a similar safety pro-
file for OR and PR surgical settings for patients who under-
went oCTR. Rates of pooled major medical complications 
were low and similar following oCTR performed in either 
setting, as were pooled surgical site/wound complications 
and iatrogenic complications. In light of these findings sup-
porting a similar safety profile, prior studies illustrating a 
substantial cost reduction associated with use of the PR set-
ting for oCTR when compared with the OR,3–13 and similar 
clinical outcomes following oCTR performed in PR and 
OR settings,33 we conclude that the value of utilizing the PR 
setting for oCTR is greater than that of the OR.
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